Weizmann Institute of Science
The findings might help identify those at extra risk of this cancer and develop means of prevention
Inflammation promotes some of the deadliest cancers. In the colon, inflammatory bowel disease is well known to be associated with higher-than-average rates of malignancy. Nevertheless, the developing tumor is commonly diagnosed only when it has already advanced or even metastasized, possibly because the early symptoms of malignancy are often mistakenly ascribed to a flare-up of intestinal inflammation. Weizmann Institute of Science researchers have now revealed a molecular missing link between chronic gut inflammation and cancer. This revelation may help develop ways of preventing colon cancers in people with inflammatory diseases of the intestines.
New-york
United-states
Memorial-sloan-kettering-cancer-center
London
City-of
United-kingdom
Shimrit-mayer
Liorh-katz
Gil-friedman
Reinat-nevo
Ido-laish
Hagar-lavon